Tag: nasdaq:tbio

March 26, 2019

Translate Bio Granted US Patent Relating to Messenger RNA Delivery

Translate Bio (NASDAQ:TBIO) has announced that the United States Patent and Trademark Office (USPTO) has issued patent number 10,238,754 to...
December 4, 2018

Translate Bio Expands Patent Portfolio with Newly Issued U.S. Patent Relating to Its Messenger RNA Therapeutics Platform

Translate Bio (Nasdaq:TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat...
July 9, 2018

Translate Bio Announces Closing of Collaboration and Licensing Agreement with Sanofi Pasteur to Develop mRNA Vaccines for Infectious Diseases

Translate Bio (Nasdaq:TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat...
June 28, 2018

Translate Bio Announces Pricing of Initial Public Offering

Translate Bio (Nasdaq:TBIO) a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat...